The molecular dynamics of MDM2

Cell Cycle

Volumn 9, Issue 10, 2010, Pages 1878-1881

  Nicholson, Judith ^a   Hupp, Ted R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53;

EDITORIAL; EUKARYOTE; MOLECULAR DYNAMICS; MOLECULAR MODEL; PLASTICITY; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 77953639998     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.10.11597     Document Type: Editorial

References (21)

1. Lane DP, Fang Cheok C, Brown C, Madhumalar A, Ghadessy FJ, Verma C. MDM2 and p53 are highly conserved from placozoans to man. Cell Cycle 2010; 9.
2. McCoy MA, Gesell JJ, Senior MM, Wyss DF. Flexible lid to the p53-binding domain of human Mdm2: Implications for p53 regulation. Proc Natl Acad Sci USA 2003; 100:1645-8.
3. Uhrinova S, Uhrin D, Powers H, Watt K, Zheleva D, Fischer P, et al. Structure of Free MDM2 N-terminal Domain Reveals Conformational Adjustments that Accompany p53-Binding. J Mol Biol 2005; 350:587-98.
4. Worrall E, Wawrzynow B, Worrall L, Walkinshaw M, Ball K, Hupp T. Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif. J Chem Biol 2009; 2:113-29.
5. Lindstrom MS, Jin A, Deisenroth C, White Wolf G, Zhang Y. Cancer-Associated Mutations in the MDM2 Zinc Finger Domain Disrupt Ribosomal Protein Interaction and Attenuate MDM2-Induced p53 Degradation. Mol Cell Biol 2007; 27:1056-68.
6. Kostic M, Matt T, Martinez-Yamout MA, Dyson HJ, Wright PE. Solution Structure of the Hdm2 C2H2C4 RING, a Domain Critical for Ubiquitination of p53. J Mol Biol 2006; 363:433-50.
7. Wawrzynow B, Pettersson S, Zylicz A, Bramham J, Worrall E, Hupp TR, et al. A Function for the RING Finger Domain in the Allosteric Control of MDM2 Conformation and Activity. J Biol Chem 2009; 284:11517-30.
8. Poyurovsky MV, Jacq X, Ma C, Karni-Schmidt O, Parker PJ, Chalfie M, et al. Nucleotide Binding by the MDM2 RING Domain Facilitates Arf-Independent MDM2 Nucleolar Localization. Molecular Cell 2003; 12:875-87.
9. Candeias MM, Malbert-Colas L, Powell DJ, Daskalogianni C, Maslon MM, Naski N, et al. p53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol 2008; 10:1098-105.
10. Wallace M, Worrall E, Pettersson S, Hupp TR, Ball KL. Dual-Site Regulation of MDM2 E3-Ubiquitin Ligase Activity. Molecular Cell 2006; 23:251-63.
11. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain. Science 1996; 274:948-53.
12. Shimizu H, Burch LR, Smith AJ, Dornan D, Wallace M, Ball KL, et al. The Conformationally Flexible S9-S10 Linker Region in the Core Domain of p53 Contains a Novel MDM2 Binding Site Whose Mutation Increases Ubiquitination of p53 in Vivo. J Biol Chem 2002; 277:28446-58.
13. Yu GW, Rudiger S, Veprintsev D, Freund S, Fernandez-Fernandez MR, Fersht AR. The central region of HDM2 provides a second binding site for p53. Proc Natl Acad Sci USA 2006; 103:1227-32.
14. Khoo KH, Joerger AC, Freund SMV, Fersht AR. Stabilizing the DNA-binding domain of p53 by rational design of its hydrophobic core. Protein Eng Des Sel 2009; 22:421-30.
15. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2. Science 2004; 303:844-8.
16. Bottger V, Bottger A, Garcia-Echerverria CG, Ramos YFM, van der Eb AJ, Jochemsen AG, Lane DP. Comparative study of the p53-MDM2 and p53-MDMX interfaces. Oncogene 1999; 18:189-99.
17. Phan J, Li Z, Kasprzak A, Li B, Sebti S, Guida W, et al. Structure-based design of high-affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX. J Biol Chem 2009.
18. Dastidar S, Lane D, Verma C. Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100. BMC Bioinformatics 2009; 10:6.
19. Pettersson S, Kelleher M, Pion E, Wallace M, Ball KL. Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2. Biochem J 2009; 418:575-85.
20. Uversky VN, Oldfield CJ, Dunker AK. Intrinsically Disordered Proteins in Human Diseases: Introducing the D2 Concept. Annual Review of Biophysics 2008; 37:215-46.
21. Dastidar SG, Lane DP, Verma CS. Multiple Peptide Conformations Give Rise to Similar Binding Affinities: Molecular Simulations of p53-MDM2. J Am Chem Soc 2008; 130:13514-5.